Inventor · disambiguated record
Nasrin R. Mawji
Also filed as: MAWJI NASRIN · MAWJI NASRIN R
14 granted patents·15 pending applications·113 citations·filing 2009–2024
92Inventor score
Files withUNIV BRITISH COLUMBIA16BRITISH COLUMBIA CANCER AGENCY BRANCH5SADAR MARIANNE D4ANDERSEN RAYMOND JOHN1BRITISH COLUMBIA CANCER AGENCY1
Top patents by PatentIndex Score
29 records- 0195US11345670B2Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2020·Granted May 31, 2022·5 cites·31 claims
- 0294US11142508B2Bisphenol derivatives and their use as androgen receptor activity modulatorsUNIV BRITISH COLUMBIA·Filed 2020·Granted Oct 12, 2021·4 cites·24 claims
- 0394US10654811B2Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2016·Granted May 19, 2020·11 cites·37 claims
- 0493US8686050B2Diglycidic ether derivative therapeutics and methods for their useBRITISH COLUMBIA CANCER AGENCY·Filed 2013·Granted Apr 1, 2014·19 cites·14 claims
- 0592US9173939B2Ester derivatives of androgen receptor modulators and methods for their useUNIV BRITISH COLUMBIA·Filed 2014·Granted Nov 3, 2015·20 cites·29 claims
- 0689US9862667B2Diglycidic ether derivative therapeutics and methods for their useSADAR MARIANNE D·Filed 2009·Granted Jan 9, 2018·14 cites·45 claims
- 0787US9388112B2Bisphenol derivatives and their use as androgen receptor activity modulatorsSADAR MARIANNE D·Filed 2011·Granted Jul 12, 2016·15 cites·34 claims
- 0887US9375496B2Halogenated compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2014·Granted Jun 28, 2016·16 cites·23 claims
- 0986US10471023B2Bisphenol ether derivatives and methods for using the sameUNIV BRITISH COLUMBIA·Filed 2016·Granted Nov 12, 2019·5 cites·28 claims
- 1085US2025100986A1Bisphenol derivatives and their use as androgen receptor activity modulatorsPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2024·Application pending·0 cites
- 1184US2024391883A1Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2024·Application pending·0 cites
- 1275US11919874B2Bisphenol derivatives and their use as androgen receptor activity modulatorsUNIV BRITISH COLUMBIA·Filed 2021·Granted Mar 5, 2024·0 cites·19 claims
- 1375US9682933B2Androgen receptor modulators and methods for their useBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2015·Granted Jun 20, 2017·2 cites·30 claims
- 1475US9487479B2Small molecule inhibitors of N-terminus activation of the androgen receptorSADAR MARIANNE D·Filed 2009·Granted Nov 8, 2016·2 cites·54 claims
- 1575US2022267283A1Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2022·Application pending·0 cites
- 1667US11779550B2Bisphenol ether derivatives and methods for using the sameUNIV BRITISH COLUMBIA·Filed 2020·Granted Oct 10, 2023·0 cites·10 claims
- 1759US2020206155A1Bisphenol ether derivatives and methods for using the sameUNIV BRITISH COLUMBIA·Filed 2019·Application pending·0 cites
- 1857US2018235925A1Bisphenol compounds and methods for their useBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2017·Application pending·0 cites
- 1956US2017298033A1Bisphenol derivatives and their use as androgen receptor activity modulatorsUNIV BRITISH COLUMBIA·Filed 2017·Application pending·0 cites
- 2054US2025009685A1Hydroxyphenyl-ethynyl-phenol derivatives as ar (androgen receptor) transcriptional activity modulators for use in the treatment of i.a. prostate cancerFUNDACIO INST DE RECERCA BIOMEDICA IRB BARCELONA·Filed 2022·Application pending·0 cites
- 2153US2014248263A1Bisphenol compounds and methods for their useANDERSEN RAYMOND JOHN·Filed 2012·Application pending·0 cites
- 2251US2017121261A1Diglycidic ether derivative therapeutics and methods for their useBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2016·Application pending·0 cites
- 2347US10071962B2Androgen receptor modulators and methods for their useBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2017·Granted Sep 11, 2018·0 cites·23 claims
- 2445US2017239216A1Small molecule inhibitors of n-terminus activation of the androgen receptorUNIV BRITISH COLUMBIA·Filed 2016·Application pending·0 cites
- 2543US2017056336A1Co-targeting androgen receptor splice variants and mtor signaling pathway for the treatment of castration-resistant prostate cancerBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2016·Application pending·0 cites
- 2642US2016068466A1Ester derivatives of androgen receptor modulators and methods for their useUNIV BRITISH COLUMBIA·Filed 2015·Application pending·0 cites
- 2741US2013045204A1Fluorinated bisphenol ether compounds and methods for their useUNIV BRITISH COLUMBIA·Filed 2012·Application pending·0 cites
- 2841US2016367707A1Halogenated compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2016·Application pending·0 cites
- 2935US2013109758A1Bisphenol derivative therapeutics and methods for their useSADAR MARIANNE D·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →